MedTrace Logo

Percutaneous Endovascular Arch Repair Trial (PEART) Study

NCT05872282 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2024-01-02

No results posted yet for this study

Summary

This study is the feasible study on a new technique of ZIPPER aortic arch stentgraft system

Conditions

  • Aortic Diseases

Interventions

DEVICE

ZIPPER aortic arch stentgraft system

The ZIPPER aortic arch stentgraft system consists of the arch mainbody stentgraft system, the branch artery stentgraft system and the thoracic extension stentgraft system.

Sponsors & Collaborators

  • Wayne W.Zhang , Seattle，Washington，USA

    collaborator UNKNOWN

  • Hangzhou Endonom Medtech Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Wayne W. Zhang · Seattle，Washington，USA

  • Weiguo Fu · Fudan University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-28
Primary Completion
2025-04-28
Completion
2025-04-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05872282 on ClinicalTrials.gov